1. Home
  2. WK vs BLCO Comparison

WK vs BLCO Comparison

Compare WK & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WK
  • BLCO
  • Stock Information
  • Founded
  • WK 2008
  • BLCO 1853
  • Country
  • WK United States
  • BLCO Canada
  • Employees
  • WK N/A
  • BLCO N/A
  • Industry
  • WK Computer Software: Prepackaged Software
  • BLCO Ophthalmic Goods
  • Sector
  • WK Technology
  • BLCO Health Care
  • Exchange
  • WK Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • WK 4.5B
  • BLCO 4.9B
  • IPO Year
  • WK 2014
  • BLCO 2022
  • Fundamental
  • Price
  • WK $85.41
  • BLCO $14.67
  • Analyst Decision
  • WK Strong Buy
  • BLCO Hold
  • Analyst Count
  • WK 10
  • BLCO 12
  • Target Price
  • WK $102.20
  • BLCO $15.82
  • AVG Volume (30 Days)
  • WK 765.1K
  • BLCO 548.7K
  • Earning Date
  • WK 11-05-2025
  • BLCO 10-29-2025
  • Dividend Yield
  • WK N/A
  • BLCO N/A
  • EPS Growth
  • WK N/A
  • BLCO N/A
  • EPS
  • WK N/A
  • BLCO N/A
  • Revenue
  • WK $806,977,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • WK $21.48
  • BLCO $8.27
  • Revenue Next Year
  • WK $15.90
  • BLCO $5.73
  • P/E Ratio
  • WK N/A
  • BLCO N/A
  • Revenue Growth
  • WK 19.02
  • BLCO 8.81
  • 52 Week Low
  • WK $60.50
  • BLCO $10.45
  • 52 Week High
  • WK $116.83
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • WK 56.55
  • BLCO 49.46
  • Support Level
  • WK $82.68
  • BLCO $14.40
  • Resistance Level
  • WK $93.00
  • BLCO $15.25
  • Average True Range (ATR)
  • WK 3.17
  • BLCO 0.41
  • MACD
  • WK 0.22
  • BLCO -0.05
  • Stochastic Oscillator
  • WK 46.64
  • BLCO 42.12

About WK Workiva Inc.

Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: